Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies

Malignancies of the peritoneal cavity are associated with a dismal prognosis. Systemic chemotherapy is the gold standard for patients with unresectable peritoneal disease, but its intraperitoneal effect is hampered by the peritoneal-plasma barrier. Intraperitoneal chemotherapy, which is administered...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs (New York, N.Y.) N.Y.), 2023-02, Vol.83 (2), p.159-180
Hauptverfasser:	Guchelaar, Niels A. D., Noordman, Bo J., Koolen, Stijn L. W., Mostert, Bianca, Madsen, Eva V. E., Burger, Jacobus W. A., Brandt-Kerkhof, Alexandra R. M., Creemers, Geert-Jan, de Hingh, Ignace H. J. T., Luyer, Misha, Bins, Sander, van Meerten, Esther, Lagarde, Sjoerd M., Verhoef, Cornelis, Wijnhoven, Bas P. L., Mathijssen, Ron. H. J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antineoplastic drugs Antitumor agents Ascites Cancer therapies Chemotherapy Colorectal carcinoma Complications Drug dosages Drugs Female Gastric cancer Health services Humans Internal Medicine Laparoscopy Malignancy Medical prognosis Medicine Medicine & Public Health Mesothelioma Molecular weight Ovarian cancer Ovarian Neoplasms - drug therapy Paclitaxel Pancreatic cancer Patients Peritoneal diseases Peritoneal Neoplasms - drug therapy Peritoneum Pharmacokinetics Pharmacology/Toxicology Pharmacotherapy Plasma Prospective Studies Quality of Life Review Review Article Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Surgery Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!